CASP3 and colorectal cancer: To assess the effect of IGF-I on the activities of the main caspases (caspase 3/7, 8 and 9) in colorectal cancer cells, we treated the human HT-29 cell line with different concentrations of recombinant human IGF-I for 24 and 48 hours.